Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR

Journal of Virological Methods

Volumn 106, Issue 1, 2002, Pages 81-88

  Rohr, Ulrich Peter ^a   Wulf, Marc Andre ^a   Stahn, Susanne ^a   Steidl, Ulrich ^a   Haas, Rainer ^a   Kronenwett, Ralf ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

rAAV 2; Real time PCR; Titration

Indexed keywords

ADENOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE FREQUENCY; GENE SEQUENCE; GENE THERAPY; HELA CELL; HUMAN; HUMAN CELL; HYBRIDIZATION; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; RELIABILITY; SIGNAL TRANSDUCTION; VIRUS GENOME; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS TITRATION;

CYTOMEGALOVIRUS; DEPENDOVIRUS; DNA, VIRAL; FLOW CYTOMETRY; GENETIC VECTORS; HELA CELLS; HUMANS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RECOMBINATION, GENETIC; REPRODUCIBILITY OF RESULTS; TIME FACTORS; VIRION;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; CUCUMBER MOSAIC VIRUS;

EID: 0036805547     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(02)00138-6     Document Type: Article

References (23)

1. Atkinson E.M., Debelak D.J., Hart L.A., Reynolds T.C. A high-throughput hybridization method for titer determination of viruses and gene therapy vectors. Nucl. Acids Res. 26:1998;2821-2823.
2. Cao L., Liu Y., During M.J., Xiao W. High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids. J. Virol. 74:2000;11 456-11 463.
3. Clark K.R., Liu X., McGrath J.P., Johnson P.R. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum. Gene Ther. 10:1999;1031-1039.
4. Clark K.R., Voulgaropoulou F., Johnson P.R. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Ther. 3:1996;1124-1132.
5. Drittanti L., Rivet C., Manceau P., Danos O., Vega M. High throughput production, screening and analysis of adeno-associated viral vectors. Gene Ther. 7:2000;924-929.
6. Ferrari F.K., Samulski T., Shenk T., Samulski R.J. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:1996;3227-3234.
7. Fisher K.J., Gao G.P., Weitzman M.D., DeMatteo R., Burda J.F., Wilson J.M. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70:1996;520-532.
8. Flotte T.R., Solow R., Owens R.A., Afione S., Zeitlin P.L., Carter B.J. Gene expression from adeno-associated virus vectors in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 7:1992;349-356.
9. Gao G., Qu G., Burnham M.S., Huang J., Chirmule N., Joshi B., Yu Q.C., Marsh J.A., Conceicao C.M., Wilson J.M. Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo. Hum. Gene Ther. 11:2000;2079-2091.
10. Grimm D., Kern A., Rittner K., Kleinschmidt J.A. Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene Ther. 9:1998;2745-2760.
11. High K.A. Gene therapy: a 2001 perspective. Haemophilia. 7:(Suppl. 1):2001;23-27.
12. Horster A., Teichmann B., Hormes R., Grimm D., Kleinschmidt J., Sczakiel G. Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy. Gene Ther. 6:1999;1231-1238.
13. Kay M.A., Manno C.S., Ragni M.V., Larson P.J., Couto L.B., McClelland A., Glader B., Chew A.J., Tai S.J., Herzog R.W., Arruda V., Johnson F., Scallan C., Skarsgard E., Flake A.W., High K.A. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat. Genet. 24:2000;257-261.
14. Kube D.M., Srivastava A. Quantitative DNA slot blot analysis: inhibition of DNA binding to membranes by magnesium ions. Nucl. Acids Res. 25:1997;3375-3376.
15. Malik P., McQuiston S.A., Yu X.J., Pepper K.A., Krall W.J., Podsakoff G.M., Kurtzman G.J., Kohn D.B. Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line. J. Virol. 71:1997;1776-1783.
16. Pear W.S., Nolan G.P., Scott M.L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:1993;8392-8396.
17. Ruffing M., Zentgraf H., Kleinschmidt J.A. Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. J. Virol. 66:1992;6922-6930.
18. Salvetti A., Oreve S., Chadeuf G., Favre D., Cherel Y., Champion-Arnaud P., David-Ameline J., Moullier P. Factors influencing recombinant adeno-associated virus production. Hum. Gene Ther. 9:1998;695-706.
19. Samulski R.J., Chang L.S., Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:1989;3822-3828.
20. Shen Y., Muramatsu S.I., Ikeguchi K., Fujimoto K.I., Fan D.S., Ogawa M., Mizukami H., Urabe M., Kume A., Nagatsu I., Urano F., Suzuki T., Ichinose H., Nagatsu T., Monahan J., Nakano I., Ozawa K. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease. Hum. Gene Ther. 11:2000;1509-1519.
21. Veldwijk M.R., Schiedlmeier B., Kleinschmidt J.A., Zeller W.J., Fruehauf S. Superior gene transfer into solid tumour cells than into human mobilised peripheral blood progenitor cells using helpervirus-free adeno-associated viral vector stocks. Eur. J. Cancer. 35:1999;1136-1142.
22. Wagner J.A., Reynolds T., Moran M.L., Moss R.B., Wine J.J., Flotte T.R., Gardner P. Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus. Lancet. 351:1998;1702-1703.
23. Zolotukhin S., Byrne B.J., Mason E., Zolotukhin I., Potter M., Chesnut K., Summerford C., Samulski R.J., Muzyczka N. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6:1999;973-985.